Skip to content
Clinical Trials – home

Schwerpunktpraxis für Diabetes Hormone & Stoffwechsel

Verified siteinfo

Germany August-Mohl-Strasse 37, 95030 Hof, Germany

  • 1 trial recruiting
  • Type 1 diabetes mellitus · Type 2 diabetes mellitus · Obesity
  • Adults and children

About Specializations

Schwerpunktpraxis für Diabetes Hormone & Stoffwechsel in Hof, Germany specialises in clinical trials of conditions such as Type 1 diabetes mellitus, Type 2 diabetes mellitus, Obesity, Chronic kidney disease, and other specialisations. This site conducts important research.

Main research areas of the site

Endocrinology and Metabolic Disorders

The medical center is at the forefront of research in Endocrinology, focusing on innovative treatments for Type 2 Diabetes and related metabolic disorders. The ongoing studies aim to improve patient outcomes by exploring alternatives to traditional insulin therapies.

  • Type 2 Diabetes Management
  • Obesity and Overweight Treatment
  • Metabolic Syndrome

By investigating novel oral medications, the center is contributing to the development of more convenient and effective treatment options for patients with complex metabolic conditions.

Cardiovascular Research

With a strong emphasis on Cardiovascular Diseases, the center is dedicated to understanding and mitigating the risks associated with heart conditions, particularly in patients with concurrent metabolic disorders.

  • Cardiovascular Risk Reduction
  • Heart Disease Prevention
  • Integrated Care for Diabetic Patients

The research conducted here is pivotal in developing strategies to reduce major adverse cardiovascular events, thereby enhancing the quality of life for at-risk populations.

Nephrology and Chronic Kidney Disease

The center is also a leader in Nephrology, focusing on the intersection of Chronic Kidney Disease and metabolic disorders. Research efforts are directed towards innovative therapies that address the unique challenges faced by this patient group.

  • Chronic Kidney Disease Management
  • Renal Complications in Diabetes
  • Preventive Nephrology

Through its research, the center aims to improve renal outcomes and slow the progression of kidney disease in patients with diabetes and obesity.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
August-Mohl-Strasse 3795030 HofGermany
Recruiting now
1 trial
Conditions studied
5
Partner status
Verified site

More sites in HofGermany

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

2 clinical trials

A Study of Baricitinib to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes

Registered drug
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years
  • Substances:Baricitinib
  • Sponsor:Eli Lilly & Co.

Type 2 diabetes mellitus+3

Not recruiting

Evaluating Once Daily Orforglipron (LY3502970) Compared to Insulin Glargine in Adults with Type 2 Diabetes and Obesity or Overweight who Have Increased Cardiovascular Risk

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Canagliflozin
  • Sponsor:Eli Lilly & Co.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.